{"name":"Organon & Co.","slug":"organon","ticker":"OGN","exchange":"NYSE","domain":"organon.com","description":"Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.","hq":"Jersey City, NJ","founded":0,"employees":"10000","ceo":"Kevin Ali","sector":"Specialty Pharma","stockPrice":13.37,"stockChange":0.03,"stockChangePercent":0.22,"marketCap":"$3.5B","metrics":{"revenue":6216000000,"revenueGrowth":-3.5,"grossMargin":53.8,"rdSpend":443000000,"netIncome":187000000,"cash":1116000000,"dividendYield":0.6,"peRatio":14.4,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Mirena patent cliff ($1.4B at risk)","drug":"Mirena","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Organon Reports Fourth Quarter and Full Year 2023 Results","summary":"Organon reported fourth quarter and full year 2023 results, with revenue of $1.4 billion and adjusted EPS of $0.93.","drugName":"","sentiment":"neutral"},{"date":"2023-06-01","type":"deal","headline":"Organon Announces Agreement to Acquire Thea Pharmaceuticals","summary":"Organon announced an agreement to acquire Thea Pharmaceuticals, a specialty pharmaceutical company focused on women's health.","drugName":"","sentiment":"positive"},{"date":"2022-12-16","type":"regulatory","headline":"FDA Approves Imvexxy ER for Treatment of Moderate to Severe Vasomotor Symptoms","summary":"The FDA approved Imvexxy ER for the treatment of moderate to severe vasomotor symptoms associated with menopause.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFA0QzliTmgxOEM3SUVGNk5VR2ZZejc2ZzJWWGhCd1N6bDlEM2VNaGNYakRTRmdwTUl5eE84c2kxZXZYbm1oQVFpMDZJNEw1dDQtR29FTnRBTUF6RE1YQkJCTEJyWXFDUHh2OF8wNE84ZXNOaWE3THQ2Nw?oc=5","date":"2026-02-23","type":"pipeline","source":"Yahoo Finance","summary":"Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7% - Yahoo Finance","headline":"Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOTW5jTnk1akpMcGhtWlVIbmt3UTcyeWJvOGFEOFE5REd6am9FWDAwV3Z2a2JLWkw2Nl9nODBwYXR1OTNwSkJ4ZE5ZZFZPeDVUNUZuUmpfLS1iQnRWRUlNYnhabTZESXYtR2g5eVJpbHlINktLZGpub0laM3JIUU9qSDZ2YWt2NHFkY05yTFg2WmJ6LWZ3bnkzakgwanYyZWZHMVlzV2g0bHZGcVdjYlVBeV9fSW1uUmRZTjU3ankyQjk?oc=5","date":"2026-02-04","type":"pipeline","source":"AD HOC NEWS","summary":"Organon & Co: Can This Beaten-Down Women’s Health Specialist Finally Turn a Corner? - AD HOC NEWS","headline":"Organon & Co: Can This Beaten-Down Women’s Health Specialist Finally Turn a Corner?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-29","type":"pipeline","source":"simplywall.st","summary":"The Market Lifts Organon & Co. (NYSE:OGN) Shares 25% But It Can Do More - simplywall.st","headline":"The Market Lifts Organon & Co. (NYSE:OGN) Shares 25% But It Can Do More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQeFRfcW5ERTFBaHpheXVSMUZYVlhHemswdy1GVnpKb3NjTW1XRFlya0lIOVpIRTBLV3FwU1dPcVpQWk1rVlRvZC1DUlRxSnFhcnFnV3c5ZFdFVGlyWGJWS2lWRWRrSlJCMVJDN0dkeWtveG5IUjlPZzgzWXJZQmJldUJTWU1lMnF4MlM1NVF3M3l5dFFvSGhndHd5T1JmRHJUa3diYnVZcVBVWEhHR3dOeDNUZy1Hb245d1pN?oc=5","date":"2026-01-23","type":"pipeline","source":"Sahm","summary":"Sun Pharma Bid Puts Organon Valuation And Growth Prospects In Focus - Sahm","headline":"Sun Pharma Bid Puts Organon Valuation And Growth Prospects In Focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOdm9DMmhIV3VXR0U5NF9ZMkJieTQzeWF5am96VW16aUJMRjJpUGhxX1kwMU9qREt5WklpWWJzcFg4TXhFeXg3TEM5bWI2S2pNdUVoY2ZmSnV5aTZiYndIZzF2Q3c5LXBjeW40ZFNfQ216OTgyYWUzUjB0VE9ObXJSaWd5eVFxUWo5bzhuREVvdmZMV1BZVWM0QzJwd19wOWk2aHhVUUFrTVk5UmFIMDFPbm9PRDU1bUM2cnlTQk9STVdYeHhPbm5GQ0w1cUpzUF9INXR5bWoxWGlVUXZWWElmZnNieVhGNXR0VTlveHMxN0R3WjJ3QmJuUQ?oc=5","date":"2026-01-22","type":"pipeline","source":"Whalesbook","summary":"Sun Pharma Weighs Potential $10 Billion Bid for Organon; Shares See Volatility - Whalesbook","headline":"Sun Pharma Weighs Potential $10 Billion Bid for Organon; Shares See Volatility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOaFFMZ0YwQ0cwZnZUd2ZJaE5lRzZIS09ZZDFYdGstYXRSNXlmeEJzVXpCYTJ5M0laSHc3RU05dHBDMlJBRWcwWUM3UmtnWXdybFdxYUJLbXRSY1RNU2NqVWNMdTZ1elYxLS1CMUJ2Zm1GMXdUMDVaQW1ST0p3M0V0cElWbDNzelRDZktJY0FobWZrS1VKdlZycFNQYm5YcFFNY0hYSThPdnc3Qy1VWXBNOURKVEJ3Zw?oc=5","date":"2026-01-21","type":"pipeline","source":"bloomberg.com","summary":"India’s Biggest Pharma Firm Said to Mull Bid for New York-Listed Organon - bloomberg.com","headline":"India’s Biggest Pharma Firm Said to Mull Bid for New York-Listed Organon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQTjZLUTlVakV3V2RsOWtyZHZDRWg2ZzloMzVtdUcySkw4U2QzQXJLWDRNeHhOWGdpNGZJTjVCNkphWWdsMlZ4eUJOWGo1QTNXM01iVWlFRGFmaUFmVkxTZERxRk9VRE5BS3BVXzBpYkt6UENqQVk3UW5nbWE2bE15WWdn?oc=5","date":"2026-01-20","type":"pipeline","source":"Yahoo Finance","summary":"Why Are Organon (OGN) Shares Soaring Today - Yahoo Finance","headline":"Why Are Organon (OGN) Shares Soaring Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNMENKaHJLS2dGeHRjS3RsclBrUjBjbndmc2V4Y0RTLVFqVVNoUDFGT2pFcjVGUUpabmljaDNGN2tmSmQzeVVhLUJIN0lEZ1Z6V0hfUUdNeVR4OUtaeEpBZlZ3SU5QdktrNllITU9xbF8xdlhOMm5GQWlwZTNjWV9DYXZ3Xzh3VGNIaUtDdFd1T0F5U2xMYXRUWXc0RlhpRFktVVJtWi1XRzBOek5ZOU9ieEdfWmVXVzd6WHhrb1dwa1V2YUkxMExpc1h1MVBkNFE?oc=5","date":"2026-01-20","type":"pipeline","source":"MSN","summary":"Organon gains on report of Sun Pharmaceutical interest - MSN","headline":"Organon gains on report of Sun Pharmaceutical interest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNRXFYQ2NxRTB2Q1drLUliTFNMTkVKMVRoM3FBeGczem9va0VucFJIMHZXSENaVHhCTFBFeWZpTEtQRmhCbGg4Wnk5SnhCMDZLVF9yanY1X25qNThpcVNNZlpxbFhCTGZ2eHR6LUlTT2gxREJ3cEluNHJRZXE0TmFIekNvVF9FNW1qTW04MVNpSDBVMHhxRkxmTm1lTXpfWU1vNVFiOExGeDAyOWdPZ2V4STRTREFhTDRpT0xVeUhQdE42LWtNS0E4VFdCNA?oc=5","date":"2026-01-20","type":"deal","source":"Benzinga","summary":"Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report - Benzinga","headline":"Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQUWFEd1VMMXA4ejZlTzBXbXJjb1JrbjZJYVpBbkVzU0F2T1FOQWZnMDlmQ00wZEc4ZEdlb2ZtM0VXU1NhYkI3Y2R0QzkxZkNPc3BnbXU1SDVUcmpYLTU3V1JucERjczY3SUtiRE4zanQwRFZfc05aY2xTeEpXY0pMVlhjYmJLSmI3ZndxbDBNWnVnYzFBODhXdDJPM3lwTkR4ekJYVUNfeUhNLU5PVG9rdmF4RGhxVFd4WUlKX0FwWHJkQQ?oc=5","date":"2026-01-19","type":"pipeline","source":"Investing.com","summary":"India’s Sun Pharma weighs $10 bln bid for US-listed Organon, ET reports - Investing.com","headline":"India’s Sun Pharma weighs $10 bln bid for US-listed Organon, ET reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNd19HRmE5S1FpdDA1SWllVjVUVEpSbVRpMl9kQ05oVjU2emNQbHBJTGt1eUtZYXctN2xRbzJkUlhOcEZHSTdDT0FHVTVnT1VPS08tMzdDYzROWTV0emJSMDJVU0tERm9LQllGNHVuR255UFJ5c09fWDlqVTRWSHQ5bE5lU1NPSml2bmxCa3ZwdUJCdURqaGRuQkxhNGJnblZOTDBWYXhwQXpSb3lzSmtFa2VHWlhBbXFrZG5kSWktVzJGQQ?oc=5","date":"2026-01-19","type":"deal","source":"TradingView","summary":"Sun Pharma terms $10-billion Organon buy report as 'speculative' - TradingView","headline":"Sun Pharma terms $10-billion Organon buy report as 'speculative'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPcFNMLU1wVEFNTTVEUjJwWVBOdjZIOEpveFhNLVpUYlN5QkliZnc4X3diOEhNZUNnclJROHZleVppVUpMcnJHQk5EMHY1Ymx3MWcySGlDaDFfLXo0TUdtZ0k3SWVxVWIzWnRrYmRucXlna1ZvYjZ5NVpIX3dpY3V1RGMyWWN6Uzl3eFlac2JJa2J3c0w1SzZjcw?oc=5","date":"2025-05-08","type":"pipeline","source":"Seeking Alpha","summary":"Organon: Management Slashes Dividend - This Feels Disastrous (NYSE:OGN) - Seeking Alpha","headline":"Organon: Management Slashes Dividend - This Feels Disastrous (NYSE:OGN)","sentiment":"neutral"}],"patents":[{"drugName":"Mirena","drugSlug":"levonorgestrel-releasing-intrauterine-system","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":1400000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Pfizer","AbbVie","Merck & Co."],"therapeuticFocus":["Women's Health","Reproductive Medicine"],"financials":{"source":"sec_edgar+yahoo","revenue":6216000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":6216000000,"period":"2025-12-31"},{"value":6403000000,"period":"2024-12-31"},{"value":6403000000,"period":"2024-12-31"},{"value":6263000000,"period":"2023-12-31"},{"value":6263000000,"period":"2023-12-31"}],"grossProfit":3313000000,"grossProfitHistory":[{"period":"2025-12-31","value":3313000000},{"period":"2024-12-31","value":3715000000},{"period":"2023-12-31","value":3748000000},{"period":"2022-12-31","value":3880000000}],"rdSpend":443000000,"rdSpendHistory":[{"period":"2025-12-31","value":366000000},{"period":"2024-12-31","value":469000000},{"period":"2023-12-31","value":528000000},{"period":"2022-12-31","value":471000000}],"sgaSpend":1721000000,"operatingIncome":1226000000,"operatingIncomeHistory":[{"period":"2025-12-31","value":1226000000},{"period":"2024-12-31","value":1486000000},{"period":"2023-12-31","value":1327000000},{"period":"2022-12-31","value":1705000000}],"netIncome":187000000,"netIncomeHistory":[{"period":"2025-12-31","value":187000000},{"period":"2024-12-31","value":864000000},{"period":"2023-12-31","value":1023000000},{"period":"2022-12-31","value":917000000}],"eps":0.72,"epsHistory":[{"period":"2025-12-31","value":0.72},{"period":"2024-12-31","value":3.33},{"period":"2023-12-31","value":3.99},{"period":"2022-12-31","value":3.59}],"cash":574000000,"cashHistory":[{"period":"2025-12-31","value":574000000},{"period":"2024-12-31","value":675000000},{"period":"2023-12-31","value":693000000},{"period":"2022-12-31","value":706000000}],"totalAssets":12867000000,"totalLiabilities":12115000000,"totalDebt":8644000000,"equity":752000000,"operatingCashflow":700000000,"operatingCashflowHistory":[{"period":"2025-12-31","value":700000000},{"period":"2024-12-31","value":939000000},{"period":"2023-12-31","value":799000000},{"period":"2022-12-31","value":858000000}],"capex":-316000000,"capexHistory":[{"period":"2025-12-31","value":-316000000},{"period":"2024-12-31","value":-351000000},{"period":"2023-12-31","value":-261000000},{"period":"2022-12-31","value":-427000000}],"freeCashflow":384000000,"dividendsPaid":-88000000,"buybacks":null,"employees":10000,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":424000000,"ebit":324000000,"ebitda":410000000,"period":"2026-03-31","revenue":1460000000,"epsBasic":0.55,"netIncome":146000000,"rdExpense":93000000,"epsDiluted":0.55,"grossProfit":783000000,"operatingIncome":266000000},{"sga":433000000,"ebit":-27000000,"ebitda":69000000,"period":"2025-12-31","revenue":1507000000,"epsBasic":-0.79,"netIncome":-205000000,"rdExpense":91000000,"epsDiluted":-0.79,"grossProfit":741000000,"operatingIncome":217000000},{"sga":415000000,"ebit":371000000,"ebitda":463000000,"period":"2025-09-30","revenue":1602000000,"epsBasic":0.61,"netIncome":160000000,"rdExpense":84000000,"epsDiluted":0.61,"grossProfit":857000000,"operatingIncome":358000000},{"sga":453000000,"ebit":360000000,"ebitda":449000000,"period":"2025-06-30","revenue":1594000000,"epsBasic":0.56,"netIncome":145000000,"rdExpense":95000000,"epsDiluted":0.56,"grossProfit":874000000,"operatingIncome":326000000},{"sga":420000000,"ebit":225000000,"ebitda":309000000,"period":"2025-03-31","revenue":1513000000,"epsBasic":0.34,"netIncome":87000000,"rdExpense":96000000,"epsDiluted":0.33,"grossProfit":841000000,"operatingIncome":325000000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":13.37,"previousClose":13.34,"fiftyTwoWeekHigh":13.44,"fiftyTwoWeekLow":5.69,"fiftyTwoWeekRange":"5.69 - 13.44","fiftyDayAverage":8.75,"twoHundredDayAverage":8.59,"beta":1.55,"enterpriseValue":10956095488,"forwardPE":3.7,"priceToBook":3.89,"priceToSales":0.57,"enterpriseToRevenue":1.78,"enterpriseToEbitda":6.87,"pegRatio":0,"ebitda":1595000064,"ebitdaMargin":25.9,"freeCashflow":529124992,"operatingCashflow":850000000,"totalDebt":8568999936,"debtToEquity":948.9,"currentRatio":1.97,"returnOnAssets":5.9,"returnOnEquity":34,"analystRating":"3.2 - Hold","recommendationKey":"hold","numberOfAnalysts":4,"targetMeanPrice":11.25,"targetHighPrice":14,"targetLowPrice":8,"dividendRate":0.08,"payoutRatio":0.09,"fiveYearAvgDividendYield":0,"exDividendDate":1778457600,"insiderHeldPercent":0.4,"institutionHeldPercent":76.6,"sharesOutstanding":262600862,"floatShares":260996371,"sharesShort":19493725,"shortRatio":1.18,"shortPercentOfFloat":7.4,"epsTrailing":0.93,"epsForward":3.66,"revenuePerShare":23.69,"bookValue":3.44,"officers":[{"age":66,"name":"Ms. Carrie Smith Cox","title":"Executive Chair of the Board"},{"age":60,"name":"Mr. Joseph T. Morrissey Jr.","title":"Chief Executive Officer"},{"age":58,"name":"Mr. Matthew M. Walsh C.F.A.","title":"Executive VP & CFO"},{"age":49,"name":"Ms. Rachel A. Stahler","title":"Executive VP, Chief Information Officer and Chief Digital & Growth Officer"},{"age":52,"name":"Mr. Kirke  Weaver","title":"Executive VP, General Counsel & Corporate Secretary"},{"age":54,"name":"Dr. Juan Camilo Arjona Ferreira M.D.","title":"Executive VP, Head of Research & Development and Chief Medical Officer"},{"age":null,"name":"Ms. Jennifer  Halchak","title":"Head of Investor Relations"},{"age":47,"name":"Mr. Daniel  Karp","title":"Chief Strategy Officer & Head of Corporate Development"}],"industry":"Drug Manufacturers - General","irWebsite":"","website":"https://www.organon.com","phone":"551 430 6900"}}